Mineralys Therapeutics, Inc. (MLYS)
24.07
+0.79
(+3.39%)
USD |
NASDAQ |
Mar 20, 16:00
24.06
-0.01
(-0.04%)
After-Hours: 20:00
Mineralys Therapeutics EPS Diluted (Quarterly) : -0.4002 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -1.538 |
| Nektar Therapeutics | -1.778 |
| Syndax Pharmaceuticals, Inc. | -0.7786 |
| Cogent Biosciences, Inc. | -0.6934 |
| Lyell Immunopharma, Inc. | -6.622 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.23M |
| Total Expenses (Quarterly) | 32.23M |
| Enterprise Value | 1.327B |
| Earnings Yield | -9.88% |
| Normalized Earnings Yield | -9.882 |